OXYGEN

OXYGEN was reported 50900 times

OXYGEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE WIRELESS COMMUNICATION ISSUE 108 0.4170
1 DEVICE MAINTENANCE ISSUE 168 0.2857
2 POST-TUSSIVE VOMITING 40 0.2454
3 OXYGEN CONSUMPTION INCREASED 540 0.2258
4 PATIENT DISSATISFACTION WITH DEVICE 52 0.2063
5 BENDOPNOEA 38 0.1727
6 DEPENDENCE ON OXYGEN THERAPY 81 0.1643
7 PULMONARY ARTERIAL PRESSURE ABNORMAL 38 0.1319
8 OXYGEN SUPPLEMENTATION 97 0.1311
9 INFUSION SITE DISCHARGE 224 0.1276
10 WALKING DISTANCE TEST ABNORMAL 48 0.1228
11 CATHETER SITE PRURITUS 101 0.1150
12 CATHETER SITE RASH 49 0.1084
13 INFUSION SITE INFECTION 252 0.1083
14 INFUSION SITE IRRITATION 130 0.1012
15 INFUSION SITE HAEMORRHAGE 333 0.1011
16 DEVICE INFUSION ISSUE 242 0.0975
17 INFUSION SITE WARMTH 116 0.0946
18 INFUSION SITE INDURATION 137 0.0924
19 INFUSION SITE INFLAMMATION 65 0.0921
20 RETINOPATHY OF PREMATURITY 51 0.0921
21 CEREBRAL ARTERY THROMBOSIS 47 0.0914
22 OXYGEN THERAPY 147 0.0894
23 PULMONARY ARTERIAL PRESSURE INCREASED 143 0.0877
24 CHRONIC RESPIRATORY FAILURE 105 0.0869
25 BRAIN SCAN ABNORMAL 47 0.0842
26 INFUSION SITE PAIN 1062 0.0823
27 COR PULMONALE 77 0.0806
28 INFUSION SITE ERYTHEMA 677 0.0802
29 PULMONARY VENO-OCCLUSIVE DISEASE 56 0.0800
30 CATHETER SITE DISCHARGE 89 0.0792
31 DEVICE ELECTRICAL FINDING 55 0.0777
32 INFUSION SITE NODULE 74 0.0770
33 RIGHT VENTRICULAR FAILURE 536 0.0764
34 CATHETER MANAGEMENT 66 0.0734
35 TRANSPLANT EVALUATION 37 0.0728
36 CATHETER SITE ERYTHEMA 151 0.0705
37 INFUSION SITE DISCOLOURATION 62 0.0705
38 INFUSION SITE CELLULITIS 37 0.0701
39 DIZZINESS EXERTIONAL 53 0.0697
40 INFUSION SITE SWELLING 436 0.0692
41 PULMONARY ARTERIAL HYPERTENSION 966 0.0666
42 HYPERVOLAEMIA 326 0.0659
43 DEVICE ALARM ISSUE 119 0.0655
44 SEASONAL ALLERGY 911 0.0643
45 HAEMOGLOBIN INCREASED 287 0.0629
46 INFUSION SITE MASS 66 0.0607
47 OXYGEN SATURATION ABNORMAL 167 0.0588
48 CARBON DIOXIDE INCREASED 79 0.0579
49 INFUSION SITE DISCOMFORT 59 0.0569
50 OXYGEN SATURATION DECREASED 3200 0.0569
51 DYSPNOEA AT REST 161 0.0555
52 DEVICE CONNECTION ISSUE 116 0.0549
53 INFUSION SITE REACTION 163 0.0545
54 CATHETER SITE SWELLING 50 0.0534
55 PULMONARY HYPERTENSION 1097 0.0526
56 HYPERCAPNIA 157 0.0521
57 PATIENT DISSATISFACTION WITH TREATMENT 100 0.0518
58 INFUSION SITE PRURITUS 163 0.0516
59 CATHETER SITE HAEMORRHAGE 129 0.0515
60 DRUG TOLERANCE DECREASED 143 0.0509
61 DEVICE POWER SOURCE ISSUE 147 0.0503
62 IDIOPATHIC PULMONARY FIBROSIS 199 0.0503
63 SUBCUTANEOUS EMPHYSEMA 49 0.0499
64 CATHETER SITE PAIN 127 0.0489
65 DYSPNOEA EXERTIONAL 1780 0.0472
66 RESPIRATORY TRACT IRRITATION 49 0.0469
67 INFUSION SITE BRUISING 97 0.0449
68 TOTAL LUNG CAPACITY DECREASED 71 0.0444
69 BRAIN NATRIURETIC PEPTIDE INCREASED 135 0.0437
70 NOCTURNAL DYSPNOEA 52 0.0408
71 INFUSION SITE RASH 55 0.0401
72 RIGHT VENTRICULAR DYSFUNCTION 44 0.0399
73 SCLERODERMA 138 0.0379
74 PULMONARY FUNCTION TEST ABNORMAL 59 0.0378
75 RHONCHI 52 0.0376
76 VASCULAR DEVICE INFECTION 168 0.0370
77 LUNG TRANSPLANT 130 0.0367
78 HYPOXIA 1289 0.0366
79 PULMONARY PAIN 104 0.0356
80 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 50 0.0356
81 CHOKING SENSATION 193 0.0350
82 RALES 193 0.0332
83 SPUTUM INCREASED 71 0.0328
84 APGAR SCORE LOW 41 0.0318
85 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1658 0.0317
86 DERMATITIS CONTACT 355 0.0311
87 ACUTE RESPIRATORY FAILURE 596 0.0309
88 EXERCISE TOLERANCE DECREASED 175 0.0304
89 PNEUMONIA INFLUENZAL 36 0.0302
90 PRODUCTIVE COUGH 1429 0.0299
91 NASAL DRYNESS 187 0.0298
92 CATHETER SITE INFECTION 110 0.0291
93 OBSTRUCTIVE SLEEP APNOEA SYNDROME 42 0.0288
94 ORTHOPNOEA 91 0.0285
95 PAIN IN JAW 789 0.0278
96 CONCOMITANT DISEASE AGGRAVATED 170 0.0275
97 SPUTUM DISCOLOURED 261 0.0275
98 RHINOVIRUS INFECTION 107 0.0275
99 FLUID RETENTION 1390 0.0273
100 CATHETERISATION CARDIAC 121 0.0273
101 EMPHYSEMA 274 0.0271
102 DIZZINESS POSTURAL 263 0.0271
103 PNEUMOMEDIASTINUM 48 0.0265
104 BREATH SOUNDS ABNORMAL 127 0.0257
105 PULMONARY FUNCTION TEST DECREASED 111 0.0253
106 PURULENT DISCHARGE 106 0.0248
107 THERAPY NON-RESPONDER 1103 0.0245
108 CATHETER PLACEMENT 45 0.0242
109 MECHANICAL VENTILATION 46 0.0242
110 HYPERTHERMIA MALIGNANT 36 0.0242
111 DRUG TITRATION ERROR 61 0.0236
112 TRANSFUSION 246 0.0235
113 BLOOD LOSS ANAEMIA 51 0.0225
114 FLUID OVERLOAD 325 0.0223
115 MIDDLE EAR EFFUSION 49 0.0222
116 RESPIRATORY TRACT CONGESTION 349 0.0219
117 BLOOD PRESSURE SYSTOLIC DECREASED 99 0.0217
118 LOWER RESPIRATORY TRACT CONGESTION 37 0.0217
119 THROAT IRRITATION 950 0.0212
120 AREFLEXIA 56 0.0210
121 PULMONARY FIBROSIS 401 0.0209
122 HAEMOPTYSIS 583 0.0209
123 DEVICE RELATED SEPSIS 42 0.0208
124 THERMAL BURN 148 0.0208
125 HAEMATOLOGICAL INFECTION 51 0.0208
126 CARDIAC ABLATION 37 0.0207
127 PNEUMONIA VIRAL 66 0.0207
128 PARANASAL SINUS HYPERSECRETION 77 0.0202
129 CREPITATIONS 60 0.0201
130 PAINFUL RESPIRATION 48 0.0199
131 LEFT VENTRICULAR FAILURE 68 0.0197
132 COUGH 5446 0.0194
133 ANAESTHETIC COMPLICATION 52 0.0193
134 RESPIRATION ABNORMAL 133 0.0193
135 SECRETION DISCHARGE 235 0.0187
136 LUNG DISORDER 918 0.0187
137 UPPER-AIRWAY COUGH SYNDROME 153 0.0186
138 RESPIRATORY ACIDOSIS 73 0.0186
139 EPISTAXIS 1387 0.0185
140 DIASTOLIC DYSFUNCTION 57 0.0184
141 PRODUCT LEAKAGE 102 0.0182
142 SUFFOCATION FEELING 45 0.0181
143 DYSPNOEA 10168 0.0179
144 RESPIRATORY FAILURE 1304 0.0179
145 CENTRAL VENOUS CATHETERISATION 53 0.0176
146 CARDIAC FAILURE ACUTE 117 0.0175
147 HAEMATOCRIT INCREASED 40 0.0175
148 DEVICE OCCLUSION 246 0.0175
149 PULSELESS ELECTRICAL ACTIVITY 73 0.0175
150 NASAL CONGESTION 1016 0.0173
151 PARANASAL SINUS DISCOMFORT 65 0.0172
152 ATRIAL FLUTTER 136 0.0170
153 WEIGHT FLUCTUATION 178 0.0170
154 CYANOSIS 267 0.0170
155 PNEUMONIA BACTERIAL 154 0.0168
156 COVID-19 PNEUMONIA 198 0.0168
157 PULMONARY OEDEMA 749 0.0167
158 PNEUMOTHORAX 264 0.0166
159 DRY THROAT 169 0.0166
160 DEVICE OPERATIONAL ISSUE 71 0.0165
161 RESPIRATORY TRACT INFECTION 426 0.0163
162 PULMONARY CONGESTION 214 0.0162
163 PERICARDIAL EFFUSION 375 0.0162
164 OROPHARYNGEAL DISCOMFORT 146 0.0161
165 TRICUSPID VALVE INCOMPETENCE 128 0.0161
166 MULTIPLE ALLERGIES 126 0.0161
167 OEDEMA 864 0.0159
168 SINUS CONGESTION 215 0.0159
169 RESPIRATORY SYNCYTIAL VIRUS INFECTION 138 0.0158
170 BLOOD PRESSURE DIASTOLIC ABNORMAL 40 0.0157
171 SKIN ABRASION 74 0.0156
172 DEVICE FAILURE 238 0.0156
173 VASODILATATION 39 0.0155
174 RESPIRATORY DISTRESS 425 0.0154
175 INCREASED BRONCHIAL SECRETION 39 0.0152
176 BRONCHOSPASM 217 0.0152
177 LOCALISED OEDEMA 70 0.0151
178 CARDIOMEGALY 184 0.0149
179 INTENTIONAL DEVICE MISUSE 65 0.0147
180 DECREASED ACTIVITY 155 0.0144
181 THERAPY PARTIAL RESPONDER 224 0.0143
182 SINUS DISORDER 281 0.0142
183 ATELECTASIS 137 0.0142
184 IRON DEFICIENCY ANAEMIA 130 0.0141
185 DEVICE PHYSICAL PROPERTY ISSUE 107 0.0140
186 LUNG CONSOLIDATION 39 0.0139
187 ENDOTRACHEAL INTUBATION 39 0.0139
188 PULMONARY ALVEOLAR HAEMORRHAGE 78 0.0139
189 MUCORMYCOSIS 36 0.0138
190 RESPIRATORY RATE INCREASED 122 0.0137
191 INCORRECT DRUG ADMINISTRATION RATE 58 0.0136
192 APNOEA 106 0.0136
193 PULMONARY HAEMORRHAGE 106 0.0135
194 BLOOD PRESSURE DECREASED 892 0.0134
195 RETCHING 282 0.0132
196 HEART RATE ABNORMAL 73 0.0131
197 BLOOD IRON DECREASED 154 0.0130
198 HYPOPNOEA 45 0.0130
199 HYPOVENTILATION 42 0.0129
200 COMPRESSION FRACTURE 69 0.0129
201 OEDEMA PERIPHERAL 1552 0.0127
202 BRONCHIECTASIS 84 0.0125
203 PNEUMONIA 4002 0.0123
204 FIBROSIS 38 0.0123
205 CHEST DISCOMFORT 1254 0.0122
206 REHABILITATION THERAPY 47 0.0121
207 HYPOTENSION 2430 0.0121
208 NASAL DISCOMFORT 96 0.0121
209 PULMONARY THROMBOSIS 132 0.0121
210 THERAPEUTIC AGENT TOXICITY 40 0.0120
211 INCREASED UPPER AIRWAY SECRETION 61 0.0119
212 CANDIDA INFECTION 200 0.0118
213 LUNG INFECTION 184 0.0118
214 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 39 0.0118
215 BRONCHOPULMONARY ASPERGILLOSIS 91 0.0117
216 PRODUCT ADMINISTRATION INTERRUPTED 92 0.0117
217 CANDIDIASIS 47 0.0117
218 TACHYPNOEA 159 0.0117
219 PLEURAL EFFUSION 706 0.0116
220 DEVICE RELATED INFECTION 177 0.0115
221 PRESYNCOPE 279 0.0115
222 THROAT CLEARING 43 0.0115
223 HAEMORRHOIDAL HAEMORRHAGE 56 0.0115
224 PNEUMONIA FUNGAL 45 0.0114
225 NON-CARDIAC CHEST PAIN 36 0.0114
226 WHEEZING 674 0.0114
227 HAEMODYNAMIC INSTABILITY 86 0.0113
228 FAECES SOFT 82 0.0113
229 CARDIAC FAILURE CONGESTIVE 902 0.0112
230 SKIN LACERATION 122 0.0112
231 TERMINAL STATE 74 0.0111
232 LUNG INFILTRATION 97 0.0110
233 BRONCHITIS 812 0.0110
234 PSEUDOMONAS INFECTION 94 0.0110
235 RESPIRATORY DISORDER 327 0.0109
236 PULMONARY MASS 162 0.0109
237 INSURANCE ISSUE 166 0.0108
238 CARDIAC FAILURE 871 0.0108
239 ACCIDENT 129 0.0108
240 RHINORRHOEA 696 0.0108
241 SARCOIDOSIS 51 0.0107
242 ACUTE PULMONARY OEDEMA 60 0.0107
243 SUPRAVENTRICULAR EXTRASYSTOLES 36 0.0106
244 HEART RATE INCREASED 1053 0.0106
245 BLOOD POTASSIUM DECREASED 318 0.0106
246 SLEEP APNOEA SYNDROME 201 0.0105
247 LEFT VENTRICULAR HYPERTROPHY 45 0.0105
248 OROPHARYNGEAL PAIN 971 0.0105
249 GOUT 187 0.0104
250 BLOOD PRESSURE DIASTOLIC DECREASED 76 0.0103
251 DYSPHONIA 599 0.0102
252 SUPRAVENTRICULAR TACHYCARDIA 98 0.0102
253 CARDIAC DYSFUNCTION 38 0.0102
254 URINE OUTPUT DECREASED 88 0.0101
255 CARDIAC PACEMAKER INSERTION 60 0.0101
256 AORTIC STENOSIS 35 0.0100
257 BUNDLE BRANCH BLOCK RIGHT 46 0.0100
258 BLOOD PRESSURE ABNORMAL 199 0.0100
259 ASCITES 291 0.0099
260 APHONIA 138 0.0099
261 SENSITIVITY TO WEATHER CHANGE 52 0.0099
262 COMPLICATION ASSOCIATED WITH DEVICE 143 0.0098
263 UPPER RESPIRATORY TRACT INFECTION 455 0.0098
264 PROCEDURAL COMPLICATION 75 0.0098
265 CHEST PAIN 1792 0.0097
266 AORTIC VALVE INCOMPETENCE 41 0.0096
267 EAR DISCOMFORT 98 0.0095
268 HEAD DISCOMFORT 169 0.0095
269 INTERSTITIAL LUNG DISEASE 462 0.0095
270 OBSTRUCTION 38 0.0095
271 ORAL CANDIDIASIS 125 0.0095
272 BUNDLE BRANCH BLOCK LEFT 40 0.0094
273 CACHEXIA 48 0.0093
274 HAEMORRHAGIC ANAEMIA 41 0.0093
275 SNORING 35 0.0092
276 SYNCOPE 924 0.0092
277 HYPOVOLAEMIA 54 0.0092
278 OBSTRUCTIVE AIRWAYS DISORDER 102 0.0092
279 KLEBSIELLA INFECTION 46 0.0091
280 TROPONIN INCREASED 69 0.0091
281 ATRIAL FIBRILLATION 878 0.0090
282 MITRAL VALVE INCOMPETENCE 102 0.0090
283 INFUSION SITE EXTRAVASATION 56 0.0090
284 DEVICE INFORMATION OUTPUT ISSUE 70 0.0090
285 GASTROINTESTINAL MOTILITY DISORDER 48 0.0090
286 ASPIRATION 97 0.0088
287 CLOSTRIDIUM DIFFICILE COLITIS 93 0.0088
288 SINUS HEADACHE 52 0.0087
289 VENTRICULAR TACHYCARDIA 144 0.0087
290 VENTRICULAR EXTRASYSTOLES 90 0.0087
291 BODY HEIGHT DECREASED 92 0.0086
292 POST PROCEDURAL COMPLICATION 165 0.0086
293 DECUBITUS ULCER 70 0.0086
294 PERIPHERAL SWELLING 1319 0.0086
295 ILLNESS 881 0.0085
296 RIB FRACTURE 175 0.0085
297 FLUSHING 862 0.0085
298 LUNG NEOPLASM 36 0.0084
299 BRAIN FOG 132 0.0084
300 SNEEZING 188 0.0084
301 HEART RATE IRREGULAR 189 0.0084
302 GASTROENTERITIS VIRAL 151 0.0084
303 HEAD INJURY 264 0.0083
304 ANAL INCONTINENCE 75 0.0083
305 MUSCULOSKELETAL CHEST PAIN 129 0.0083
306 ATRIOVENTRICULAR BLOCK FIRST DEGREE 36 0.0083
307 CHAPPED LIPS 36 0.0083
308 LIMB INJURY 225 0.0083
309 STAPHYLOCOCCAL BACTERAEMIA 36 0.0083
310 CARDIAC FLUTTER 53 0.0082
311 HEADACHE 5135 0.0082
312 BACTERAEMIA 97 0.0082
313 GENERALISED OEDEMA 101 0.0082
314 HEART RATE DECREASED 285 0.0081
315 BLOOD MAGNESIUM DECREASED 70 0.0081
316 PRODUCT DISTRIBUTION ISSUE 75 0.0081
317 STRESS CARDIOMYOPATHY 47 0.0081
318 SCOLIOSIS 50 0.0081
319 LEFT VENTRICULAR DYSFUNCTION 54 0.0081
320 BLOOD PRESSURE FLUCTUATION 193 0.0080
321 SLUGGISHNESS 82 0.0080
322 AORTIC ANEURYSM 61 0.0080
323 INJECTION SITE DISCHARGE 43 0.0080
324 STENT PLACEMENT 64 0.0079
325 BLOOD PRESSURE SYSTOLIC INCREASED 154 0.0079
326 SINUS TACHYCARDIA 112 0.0079
327 WEIGHT DECREASED 2192 0.0078
328 HYPERSOMNIA 225 0.0078
329 ESCHERICHIA INFECTION 64 0.0078
330 ASPERGILLUS INFECTION 51 0.0078
331 WALKING AID USER 51 0.0077
332 DEVICE USE ERROR 268 0.0077
333 CARDIAC VALVE DISEASE 44 0.0077
334 HEMIPLEGIA 64 0.0077
335 FRUSTRATION TOLERANCE DECREASED 62 0.0077
336 HAEMATOCRIT DECREASED 152 0.0077
337 BLOOD UREA INCREASED 128 0.0076
338 BRADYCARDIA 404 0.0076
339 PRODUCT USE COMPLAINT 120 0.0076
340 PALPITATIONS 892 0.0076
341 ACUTE RESPIRATORY DISTRESS SYNDROME 134 0.0076
342 PULSE ABSENT 36 0.0076
343 HOSPICE CARE 74 0.0075
344 PNEUMONIA ASPIRATION 186 0.0074
345 DECREASED APPETITE 1726 0.0074
346 HYPERVENTILATION 43 0.0074
347 CLOSTRIDIUM DIFFICILE INFECTION 161 0.0074
348 DEVICE DISLOCATION 320 0.0074
349 PNEUMONITIS 200 0.0073
350 HEPATOMEGALY 72 0.0073
351 DIZZINESS 3637 0.0073
352 CARDIAC ARREST 600 0.0073
353 PLEURISY 43 0.0072
354 SINUSITIS 738 0.0072
355 PELVIC FRACTURE 56 0.0072
356 HIATUS HERNIA 93 0.0072
357 POLYP 47 0.0072
358 FEEDING DISORDER 144 0.0071
359 WRIST FRACTURE 85 0.0071
360 NASOPHARYNGITIS 1305 0.0071
361 DIARRHOEA 4547 0.0070
362 RENAL FAILURE CHRONIC 54 0.0070
363 VENTRICULAR FIBRILLATION 78 0.0070
364 INFLUENZA 782 0.0070
365 CELLULITIS 353 0.0070
366 ARTERIOSCLEROSIS CORONARY ARTERY 46 0.0069
367 CARDIAC MURMUR 60 0.0069
368 CHOKING 135 0.0069
369 COAGULOPATHY 115 0.0069
370 ELECTROLYTE IMBALANCE 80 0.0069
371 BLOOD ALKALINE PHOSPHATASE INCREASED 170 0.0068
372 EAR INFECTION 182 0.0068
373 STREPTOCOCCAL INFECTION 38 0.0068
374 MOUTH HAEMORRHAGE 50 0.0068
375 BACTERIAL INFECTION 127 0.0068
376 FACIAL PARALYSIS 58 0.0068
377 PULMONARY TOXICITY 48 0.0068
378 CARDIAC DISORDER 635 0.0068
379 POOR VENOUS ACCESS 70 0.0068
380 VIRAL INFECTION 225 0.0068
381 CARDIOGENIC SHOCK 97 0.0068
382 GASTROOESOPHAGEAL REFLUX DISEASE 544 0.0068
383 BLOOD URIC ACID INCREASED 39 0.0067
384 INTERNAL HAEMORRHAGE 77 0.0067
385 MALNUTRITION 75 0.0067
386 DEVICE MALFUNCTION 471 0.0067
387 GAMMA-GLUTAMYLTRANSFERASE INCREASED 148 0.0067
388 LIGAMENT SPRAIN 66 0.0067
389 LOCALISED INFECTION 161 0.0067
390 ABDOMINAL DISTENSION 690 0.0066
391 RESPIRATORY DEPRESSION 81 0.0066
392 SEPSIS 735 0.0066
393 ATRIOVENTRICULAR BLOCK COMPLETE 44 0.0066
394 CYSTIC FIBROSIS 36 0.0065
395 MYOCARDIAL ISCHAEMIA 74 0.0065
396 DEVICE LEAKAGE 280 0.0065
397 ASTHENIA 2418 0.0064
398 SEPTIC SHOCK 279 0.0064
399 CATARACT OPERATION 38 0.0064
400 UNINTENTIONAL MEDICAL DEVICE REMOVAL 74 0.0064
401 STAPHYLOCOCCAL INFECTION 211 0.0064
402 MUSCULOSKELETAL DISCOMFORT 110 0.0064
403 BEDRIDDEN 84 0.0064
404 INTENTIONAL DOSE OMISSION 182 0.0064
405 TORSADE DE POINTES 50 0.0064
406 HYPOKALAEMIA 294 0.0064
407 PROTHROMBIN TIME PROLONGED 38 0.0063
408 LOSS OF CONSCIOUSNESS 810 0.0063
409 ABNORMAL LOSS OF WEIGHT 43 0.0063
410 OLIGURIA 39 0.0063
411 FACIAL PAIN 56 0.0063
412 TACHYCARDIA 557 0.0063
413 BLOOD SODIUM DECREASED 118 0.0063
414 RESPIRATORY ARREST 172 0.0062
415 DRY MOUTH 506 0.0062
416 NECK PAIN 347 0.0062
417 FLANK PAIN 58 0.0062
418 JOINT INJURY 132 0.0062
419 FEELING COLD 172 0.0062
420 MULTIPLE ORGAN DYSFUNCTION SYNDROME 175 0.0062
421 EXTRASYSTOLES 43 0.0062
422 MUSCLE STRAIN 53 0.0061
423 FALL 2039 0.0061
424 FEELING JITTERY 116 0.0061
425 HYPOACUSIS 262 0.0061
426 RHINITIS 49 0.0061
427 DIVERTICULUM 43 0.0060
428 ABDOMINAL DISCOMFORT 1013 0.0060
429 ACIDOSIS 46 0.0060
430 FEELING ABNORMAL 1442 0.0060
431 DYSPEPSIA 592 0.0060
432 UNEVALUABLE EVENT 454 0.0060
433 POOR QUALITY SLEEP 129 0.0060
434 URINARY TRACT INFECTION 1020 0.0060
435 KIDNEY INFECTION 117 0.0060
436 HAEMOGLOBIN DECREASED 612 0.0060
437 CARDIO-RESPIRATORY ARREST 249 0.0059
438 ANAEMIA 1133 0.0059
439 HIP FRACTURE 191 0.0059
440 SPINAL COMPRESSION FRACTURE 49 0.0059
441 MULTIPLE INJURIES 37 0.0059
442 MACULAR DEGENERATION 70 0.0059
443 INTERNATIONAL NORMALISED RATIO INCREASED 167 0.0059
444 BLOOD POTASSIUM INCREASED 95 0.0058
445 ASPARTATE AMINOTRANSFERASE INCREASED 310 0.0058
446 ATRIOVENTRICULAR BLOCK 45 0.0058
447 HAEMORRHOIDS 113 0.0058
448 HYPERLIPIDAEMIA 69 0.0058
449 INGUINAL HERNIA 35 0.0057
450 PERIPHERAL COLDNESS 79 0.0057
451 POLYURIA 47 0.0057
452 APPETITE DISORDER 38 0.0057
453 GASTROINTESTINAL HAEMORRHAGE 478 0.0057
454 DEHYDRATION 762 0.0057
455 EAR PAIN 111 0.0057
456 ORAL DISCOMFORT 79 0.0057
457 ORAL PAIN 126 0.0056
458 BLOOD BILIRUBIN INCREASED 152 0.0056
459 ASTHMA 634 0.0056
460 SPINAL FRACTURE 112 0.0056
461 SINUS BRADYCARDIA 54 0.0056
462 UNRESPONSIVE TO STIMULI 144 0.0056
463 CIRCULATORY COLLAPSE 95 0.0056
464 CONTUSION 537 0.0056
465 TENDERNESS 58 0.0056
466 DEVICE ISSUE 498 0.0055
467 BODY TEMPERATURE INCREASED 113 0.0055
468 LOW BIRTH WEIGHT BABY 44 0.0055
469 GASTROINTESTINAL DISORDER 495 0.0055
470 FATIGUE 4296 0.0055
471 BACK PAIN 1278 0.0055
472 MALAISE 2412 0.0055
473 PREMATURE BABY 165 0.0055
474 GASTROINTESTINAL INFECTION 49 0.0055
475 SPINAL OSTEOARTHRITIS 48 0.0055
476 WEIGHT INCREASED 1217 0.0054
477 CYTOKINE RELEASE SYNDROME 109 0.0054
478 TASTE DISORDER 110 0.0054
479 SENSITIVE SKIN 40 0.0054
480 POST PROCEDURAL HAEMORRHAGE 63 0.0054
481 PALLOR 147 0.0054
482 CORONARY ARTERY OCCLUSION 74 0.0054
483 FLATULENCE 306 0.0054
484 SCIATICA 86 0.0054
485 COVID-19 946 0.0054
486 ASPHYXIA 44 0.0054
487 WHITE BLOOD CELL COUNT INCREASED 206 0.0054
488 TOOTH FRACTURE 59 0.0053
489 RED BLOOD CELL COUNT DECREASED 153 0.0053
490 GENERAL PHYSICAL HEALTH DETERIORATION 619 0.0053
491 SKIN INFECTION 60 0.0053
492 PAIN IN EXTREMITY 1571 0.0053
493 INCREASED TENDENCY TO BRUISE 49 0.0053
494 LEUKOCYTOSIS 96 0.0053
495 MENTAL STATUS CHANGES 147 0.0053
496 CATARACT 315 0.0053
497 DIALYSIS 75 0.0053
498 LOWER GASTROINTESTINAL HAEMORRHAGE 39 0.0053
499 SCAB 60 0.0053
500 NAUSEA 4124 0.0052
501 ARTERIOSCLEROSIS 49 0.0052
502 LIMB DISCOMFORT 161 0.0052
503 CONDITION AGGRAVATED 1578 0.0052
504 TREATMENT NONCOMPLIANCE 283 0.0052
505 CONCUSSION 40 0.0052
506 BLOOD CALCIUM DECREASED 58 0.0052
507 LUNG NEOPLASM MALIGNANT 211 0.0051
508 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 45 0.0051
509 PULMONARY EMBOLISM 481 0.0051
510 ANKLE FRACTURE 78 0.0050
511 SWELLING 471 0.0050
512 GASTRITIS 132 0.0050
513 GROIN PAIN 44 0.0050
514 LACERATION 47 0.0050
515 LOWER LIMB FRACTURE 96 0.0050
516 FAECES DISCOLOURED 108 0.0050
517 DISSEMINATED INTRAVASCULAR COAGULATION 70 0.0050
518 URINARY INCONTINENCE 147 0.0050
519 HAND FRACTURE 35 0.0049
520 NERVOUSNESS 257 0.0049
521 THROAT TIGHTNESS 133 0.0049
522 BLOOD ALBUMIN DECREASED 39 0.0049
523 TOOTHACHE 89 0.0049
524 DYSURIA 180 0.0049
525 DRUG INTOLERANCE 472 0.0049
526 UPPER LIMB FRACTURE 97 0.0049
527 TOOTH INFECTION 64 0.0048
528 CHILLS 567 0.0048
529 CYSTITIS 154 0.0048
530 LETHARGY 278 0.0048
531 PANIC ATTACK 176 0.0048
532 INCONTINENCE 51 0.0048
533 ALANINE AMINOTRANSFERASE INCREASED 295 0.0048
534 VITAMIN D DECREASED 41 0.0048
535 RENAL CYST 38 0.0048
536 EYE INFECTION 54 0.0048
537 HYPOALBUMINAEMIA 37 0.0048
538 MULTI-ORGAN FAILURE 82 0.0047
539 PRODUCT DOSE OMISSION ISSUE 1391 0.0047
540 UROSEPSIS 43 0.0047
541 IMMUNOSUPPRESSION 41 0.0046
542 HYPERTHYROIDISM 67 0.0046
543 RENAL DISORDER 215 0.0046
544 VOMITING 2169 0.0046
545 BACK INJURY 50 0.0046
546 ABDOMINAL PAIN UPPER 946 0.0046
547 SKIN DISCOLOURATION 211 0.0046
548 CORONARY ARTERY DISEASE 139 0.0046
549 FOOT FRACTURE 87 0.0046
550 ELECTROCARDIOGRAM ABNORMAL 36 0.0046
551 GLAUCOMA 88 0.0046
552 SHOCK 105 0.0046
553 CAESAREAN SECTION 53 0.0045
554 CONSTIPATION 990 0.0045
555 ANURIA 39 0.0045
556 INFECTION 654 0.0045
557 TOOTH ABSCESS 46 0.0045
558 AUTOIMMUNE DISORDER 44 0.0045
559 POLLAKIURIA 188 0.0045
560 METABOLIC ACIDOSIS 144 0.0045
561 PHARYNGEAL SWELLING 44 0.0045
562 MIGRAINE 429 0.0045
563 BACK DISORDER 73 0.0045
564 ARRHYTHMIA 212 0.0045
565 THYROID DISORDER 69 0.0045
566 THROMBOSIS 359 0.0045
567 HYPOPHAGIA 114 0.0045
568 DEVICE USE ISSUE 78 0.0045
569 EMBOLISM 37 0.0045
570 RESTLESS LEGS SYNDROME 81 0.0044
571 OCULAR DISCOMFORT 50 0.0044
572 PLATELET COUNT DECREASED 474 0.0044
573 FULL BLOOD COUNT ABNORMAL 47 0.0044
574 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 213 0.0044
575 PHARYNGITIS 55 0.0044
576 GASTRIC HAEMORRHAGE 51 0.0044
577 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 207 0.0044
578 GINGIVAL PAIN 35 0.0044
579 HYPOMAGNESAEMIA 61 0.0044
580 COLD SWEAT 77 0.0044
581 DIVERTICULITIS 121 0.0044
582 ECONOMIC PROBLEM 66 0.0044
583 HYPERKALAEMIA 151 0.0043
584 POST PROCEDURAL INFECTION 35 0.0043
585 DELIRIUM 149 0.0043
586 BLOOD CREATININE INCREASED 279 0.0043
587 SENSATION OF FOREIGN BODY 36 0.0043
588 BLOOD URINE PRESENT 81 0.0043
589 NO THERAPEUTIC RESPONSE 52 0.0043
590 MUSCLE ATROPHY 54 0.0043
591 BLOOD PRESSURE INCREASED 651 0.0043
592 FREQUENT BOWEL MOVEMENTS 115 0.0043
593 NEURALGIA 103 0.0042
594 INABILITY TO AFFORD MEDICATION 42 0.0042
595 DISEASE PROGRESSION 498 0.0042
596 ACUTE MYOCARDIAL INFARCTION 124 0.0042
597 HEPATIC CIRRHOSIS 79 0.0042
598 HERNIA 81 0.0042
599 SPLENOMEGALY 49 0.0042
600 AGEUSIA 104 0.0042
601 GAIT INABILITY 139 0.0042
602 ENCEPHALOPATHY 102 0.0041
603 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 71 0.0041
604 PRODUCT USE ISSUE 778 0.0041
605 MELAENA 91 0.0041
606 HYPERTENSION 875 0.0041
607 PYREXIA 1429 0.0041
608 BLOOD TEST ABNORMAL 58 0.0041
609 ROTATOR CUFF SYNDROME 53 0.0041
610 FEELING HOT 253 0.0041
611 TREMOR 684 0.0041
612 CHROMATURIA 93 0.0041
613 ARTHRITIS 323 0.0041
614 MYALGIA 698 0.0041
615 HAEMATEMESIS 104 0.0041
616 INTENTIONAL PRODUCT MISUSE 359 0.0041
617 RENAL FAILURE ACUTE 174 0.0041
618 GAIT DISTURBANCE 782 0.0041
619 RENAL TUBULAR NECROSIS 40 0.0041
620 SUDDEN DEATH 43 0.0041
621 BODY TEMPERATURE DECREASED 40 0.0041
622 TRANSIENT ISCHAEMIC ATTACK 137 0.0041
623 LIVER FUNCTION TEST ABNORMAL 118 0.0041
624 RECTAL HAEMORRHAGE 174 0.0040
625 LOWER RESPIRATORY TRACT INFECTION 184 0.0040
626 EATING DISORDER 86 0.0040
627 CHOLELITHIASIS 132 0.0040
628 MIDDLE INSOMNIA 75 0.0040
629 HAEMATOCHEZIA 220 0.0040
630 HERPES ZOSTER 229 0.0040
631 ISCHAEMIC STROKE 71 0.0040
632 HAEMATOMA 103 0.0040
633 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 714 0.0040
634 FUNGAL INFECTION 132 0.0040
635 ULCER 63 0.0040
636 HEPATIC FUNCTION ABNORMAL 147 0.0039
637 OSTEOPOROSIS 162 0.0039
638 HOSPITALISATION 605 0.0039
639 GLOMERULAR FILTRATION RATE DECREASED 48 0.0039
640 ORTHOSTATIC HYPOTENSION 68 0.0039
641 NERVE COMPRESSION 36 0.0039
642 GINGIVAL BLEEDING 53 0.0039
643 PHARYNGITIS STREPTOCOCCAL 42 0.0039
644 ERUCTATION 75 0.0039
645 QUALITY OF LIFE DECREASED 52 0.0039
646 BONE PAIN 227 0.0039
647 GALLBLADDER DISORDER 69 0.0039
648 HAEMORRHAGE 404 0.0039
649 MUSCULAR WEAKNESS 439 0.0039
650 SCAR 66 0.0039
651 JOINT SWELLING 464 0.0038
652 DYSSTASIA 111 0.0038
653 WOUND 106 0.0038
654 SKIN ULCER 98 0.0038
655 ANXIETY 1076 0.0038
656 MEMORY IMPAIRMENT 519 0.0038
657 NERVE INJURY 42 0.0038
658 HYPERTENSIVE CRISIS 42 0.0038
659 LACRIMATION INCREASED 114 0.0038
660 PARALYSIS 54 0.0038
661 THERAPY CHANGE 37 0.0038
662 INSOMNIA 999 0.0037
663 DYSPHAGIA 354 0.0037
664 METASTASES TO CENTRAL NERVOUS SYSTEM 48 0.0037
665 COLON CANCER 55 0.0037
666 GENERALISED TONIC-CLONIC SEIZURE 61 0.0037
667 PNEUMOCYSTIS JIROVECII PNEUMONIA 37 0.0037
668 TEMPERATURE INTOLERANCE 38 0.0037
669 RENAL FAILURE 488 0.0037
670 EJECTION FRACTION DECREASED 57 0.0037
671 MUSCLE SPASMS 673 0.0037
672 MASS 51 0.0036
673 MOBILITY DECREASED 262 0.0036
674 OBESITY 58 0.0036
675 THERAPY INTERRUPTED 260 0.0036
676 SOMNOLENCE 731 0.0036
677 LABORATORY TEST ABNORMAL 107 0.0036
678 HYPOTONIA 36 0.0036
679 DEAFNESS 94 0.0036
680 PRODUCT PHYSICAL ISSUE 72 0.0036
681 UPPER GASTROINTESTINAL HAEMORRHAGE 60 0.0036
682 HOT FLUSH 268 0.0036
683 MUSCULOSKELETAL PAIN 186 0.0035
684 ACUTE KIDNEY INJURY 543 0.0035
685 OSTEOMYELITIS 64 0.0035
686 HAEMATURIA 121 0.0035
687 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 60 0.0035
688 SPEECH DISORDER 185 0.0035
689 SCRATCH 37 0.0035
690 MICTURITION URGENCY 40 0.0035
691 FACE OEDEMA 59 0.0035
692 SMALL INTESTINAL OBSTRUCTION 43 0.0035
693 ANGINA PECTORIS 100 0.0035
694 BALANCE DISORDER 300 0.0035
695 INFUSION RELATED REACTION 230 0.0035
696 OSTEOARTHRITIS 147 0.0035
697 DISORIENTATION 137 0.0035
698 GASTROINTESTINAL PAIN 38 0.0035
699 PANCYTOPENIA 193 0.0034
700 HYPOAESTHESIA ORAL 52 0.0034
701 IMPAIRED GASTRIC EMPTYING 47 0.0034
702 PAIN 2116 0.0034
703 BLOOD COUNT ABNORMAL 52 0.0034
704 FULL BLOOD COUNT DECREASED 69 0.0034
705 ARTHRALGIA 1415 0.0034
706 SWELLING FACE 221 0.0034
707 SEROTONIN SYNDROME 65 0.0034
708 TOOTH EXTRACTION 42 0.0034
709 CONFUSIONAL STATE 545 0.0034
710 MYOCLONUS 40 0.0034
711 DIABETES MELLITUS 255 0.0033
712 MUSCLE TIGHTNESS 54 0.0033
713 EXTRA DOSE ADMINISTERED 135 0.0033
714 HEPATIC STEATOSIS 62 0.0033
715 PROCEDURAL PAIN 92 0.0033
716 VERTIGO 202 0.0033
717 BLOOD GLUCOSE DECREASED 159 0.0033
718 PRODUCT DOSE OMISSION 216 0.0033
719 URINARY RETENTION 110 0.0033
720 LIVER DISORDER 146 0.0033
721 HYPERGLYCAEMIA 119 0.0033
722 DRUG INTERACTION 516 0.0032
723 RENAL IMPAIRMENT 273 0.0032
724 HYPONATRAEMIA 183 0.0032
725 INTERVERTEBRAL DISC PROTRUSION 71 0.0032
726 SUBDURAL HAEMATOMA 46 0.0032
727 LOCAL SWELLING 56 0.0032
728 INTESTINAL OBSTRUCTION 121 0.0032
729 NEPHROLITHIASIS 147 0.0032
730 SLEEP DISORDER 226 0.0032
731 VISION BLURRED 438 0.0032
732 DEPRESSED MOOD 167 0.0032
733 GASTROENTERITIS 46 0.0031
734 ILL-DEFINED DISORDER 191 0.0031
735 HYPERHIDROSIS 405 0.0031
736 DRUG DOSE OMISSION 518 0.0031
737 NOCTURIA 38 0.0031
738 PARAESTHESIA ORAL 45 0.0031
739 RASH MACULAR 109 0.0031
740 ELECTROCARDIOGRAM QT PROLONGED 112 0.0031
741 IMMUNE SYSTEM DISORDER 41 0.0031
742 GASTRIC ULCER 59 0.0031
743 DEATH 2668 0.0031
744 ABDOMINAL PAIN 720 0.0031
745 BLOOD LACTATE DEHYDROGENASE INCREASED 49 0.0031
746 HEPATIC FAILURE 93 0.0031
747 EYE HAEMORRHAGE 41 0.0031
748 CARPAL TUNNEL SYNDROME 43 0.0031
749 CYST 38 0.0031
750 ILEUS 38 0.0031
751 LYMPHADENOPATHY 108 0.0030
752 BLINDNESS UNILATERAL 43 0.0030
753 FIBROMYALGIA 74 0.0030
754 EYE DISORDER 100 0.0030
755 THROMBOCYTOPENIA 340 0.0030
756 DEPRESSED LEVEL OF CONSCIOUSNESS 120 0.0030
757 IMMUNODEFICIENCY 45 0.0030
758 INFLUENZA LIKE ILLNESS 248 0.0030
759 HYPOTHYROIDISM 96 0.0030
760 PRODUCT COMPLAINT 76 0.0030
761 INJECTION SITE IRRITATION 38 0.0030
762 CARDIOMYOPATHY 44 0.0030
763 ADRENAL INSUFFICIENCY 36 0.0030
764 OSTEOPENIA 45 0.0030
765 DRUG ADMINISTRATION ERROR 91 0.0030
766 APHASIA 89 0.0029
767 ROAD TRAFFIC ACCIDENT 123 0.0029
768 VISUAL IMPAIRMENT 364 0.0029
769 MUSCLE RIGIDITY 35 0.0029
770 BLOOD GLUCOSE ABNORMAL 54 0.0029
771 ERYTHEMA 600 0.0029
772 ANAPHYLACTIC REACTION 161 0.0029
773 GLOSSODYNIA 65 0.0029
774 NEUROPATHY PERIPHERAL 275 0.0029
775 DEVICE DELIVERY SYSTEM ISSUE 79 0.0029
776 GASTRIC DISORDER 99 0.0029
777 SKIN CANCER 62 0.0029
778 TOOTH DISORDER 64 0.0029
779 ABASIA 71 0.0029
780 DYSARTHRIA 108 0.0029
781 DEMENTIA 80 0.0029
782 SICKLE CELL ANAEMIA WITH CRISIS 45 0.0029
783 RASH PRURITIC 154 0.0028
784 PLATELET COUNT INCREASED 37 0.0028
785 INTENTIONAL PRODUCT USE ISSUE 248 0.0028
786 DYSGEUSIA 210 0.0028
787 NIGHT SWEATS 91 0.0028
788 HYPOAESTHESIA 420 0.0028
789 EYE SWELLING 104 0.0028
790 PRODUCT QUALITY ISSUE 378 0.0028
791 EYE PAIN 157 0.0028
792 HEMIPARESIS 47 0.0028
793 SKIN HAEMORRHAGE 41 0.0028
794 THERAPY CESSATION 142 0.0028
795 DEVICE BREAKAGE 112 0.0028
796 HYPOCALCAEMIA 52 0.0027
797 ABDOMINAL PAIN LOWER 69 0.0027
798 SARS-COV-2 TEST POSITIVE 36 0.0027
799 PRODUCT ADMINISTRATION ERROR 55 0.0027
800 ANAPHYLACTIC SHOCK 70 0.0027
801 FEAR 73 0.0027
802 FEBRILE NEUTROPENIA 180 0.0027
803 LIVER FUNCTION TEST INCREASED 58 0.0027
804 THIRST 48 0.0027
805 DISCOMFORT 163 0.0027
806 BURNING SENSATION 187 0.0027
807 PRODUCT DOSE OMISSION IN ERROR 75 0.0026
808 OFF LABEL USE 2306 0.0026
809 INCORRECT DOSE ADMINISTERED 598 0.0026
810 VISUAL ACUITY REDUCED 87 0.0026
811 HYPOKINESIA 38 0.0026
812 RASH ERYTHEMATOUS 125 0.0026
813 ACTIVITIES OF DAILY LIVING IMPAIRED 51 0.0026
814 PREMATURE DELIVERY 41 0.0026
815 MUSCULOSKELETAL DISORDER 49 0.0026
816 MYOCARDIAL INFARCTION 449 0.0026
817 DRUG TOXICITY 35 0.0026
818 AMNESIA 167 0.0026
819 INFLAMMATION 132 0.0026
820 C-REACTIVE PROTEIN INCREASED 93 0.0026
821 STOMATITIS 154 0.0025
822 CEREBROVASCULAR ACCIDENT 428 0.0025
823 TINNITUS 116 0.0025
824 IRRITABLE BOWEL SYNDROME 54 0.0025
825 THERAPEUTIC RESPONSE UNEXPECTED 112 0.0025
826 SYSTEMIC LUPUS ERYTHEMATOSUS 88 0.0025
827 THINKING ABNORMAL 46 0.0025
828 ACCIDENTAL OVERDOSE 90 0.0025
829 FEMUR FRACTURE 76 0.0025
830 PHOTOPHOBIA 46 0.0024
831 DRUG ERUPTION 43 0.0024
832 AGITATION 178 0.0024
833 IMPAIRED HEALING 79 0.0024
834 MENTAL IMPAIRMENT 58 0.0024
835 PARAESTHESIA 376 0.0024
836 DEEP VEIN THROMBOSIS 155 0.0024
837 HYPERSENSITIVITY 442 0.0024
838 PRESCRIBED OVERDOSE 46 0.0024
839 LYMPHOCYTE COUNT DECREASED 42 0.0024
840 NEOPLASM MALIGNANT 158 0.0024
841 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 479 0.0024
842 SEIZURE 273 0.0024
843 BONE DISORDER 43 0.0024
844 PRODUCT USE IN UNAPPROVED INDICATION 578 0.0023
845 EYE PRURITUS 78 0.0023
846 LACTIC ACIDOSIS 75 0.0023
847 EXPOSURE VIA SKIN CONTACT 60 0.0023
848 INCORRECT PRODUCT ADMINISTRATION DURATION 50 0.0023
849 MOVEMENT DISORDER 74 0.0023
850 HEPATOTOXICITY 51 0.0023
851 DYSKINESIA 93 0.0023
852 CARDIOVASCULAR DISORDER 58 0.0023
853 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 125 0.0023
854 PHARYNGEAL OEDEMA 35 0.0023
855 DEVICE DIFFICULT TO USE 150 0.0023
856 BLISTER 127 0.0023
857 THERAPEUTIC RESPONSE DECREASED 137 0.0023
858 MUSCLE TWITCHING 52 0.0023
859 SKIN FISSURES 44 0.0022
860 DEPRESSION 512 0.0022
861 TRANSAMINASES INCREASED 50 0.0022
862 PSYCHOMOTOR HYPERACTIVITY 37 0.0022
863 FOETAL EXPOSURE DURING PREGNANCY 181 0.0022
864 NEUROTOXICITY 39 0.0022
865 DISABILITY 44 0.0022
866 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 57 0.0022
867 INCREASED APPETITE 42 0.0022
868 END STAGE RENAL DISEASE 40 0.0022
869 COLITIS 83 0.0022
870 JOINT STIFFNESS 57 0.0022
871 DRY EYE 108 0.0022
872 ADVERSE EVENT 199 0.0022
873 DIPLOPIA 56 0.0022
874 INTENTIONAL DRUG MISUSE 45 0.0022
875 HEPATIC ENZYME INCREASED 146 0.0021
876 ARTHROPATHY 119 0.0021
877 TYPE 2 DIABETES MELLITUS 72 0.0021
878 OCULAR HYPERAEMIA 101 0.0021
879 PRURITUS 816 0.0021
880 BLINDNESS 86 0.0021
881 RASH 906 0.0021
882 SKIN LESION 57 0.0021
883 INJURY 146 0.0021
884 MUSCULOSKELETAL STIFFNESS 181 0.0021
885 ABNORMAL DREAMS 57 0.0021
886 HYPOGLYCAEMIA 100 0.0021
887 CONJUNCTIVITIS 38 0.0020
888 MATERNAL EXPOSURE DURING PREGNANCY 182 0.0020
889 DRUG-INDUCED LIVER INJURY 64 0.0020
890 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
891 PRODUCT PRESCRIBING ERROR 48 0.0020
892 CHRONIC KIDNEY DISEASE 153 0.0020
893 SURGERY 118 0.0020
894 PHARMACEUTICAL PRODUCT COMPLAINT 52 0.0020
895 TOOTH LOSS 41 0.0020
896 BLOOD GLUCOSE INCREASED 372 0.0020
897 SWOLLEN TONGUE 61 0.0020
898 UNDERDOSE 142 0.0019
899 INJECTION SITE RASH 59 0.0019
900 PANCREATITIS ACUTE 43 0.0019
901 CRYING 69 0.0019
902 ORAL HERPES 37 0.0019
903 RHABDOMYOLYSIS 79 0.0019
904 LIP SWELLING 63 0.0019
905 RESTLESSNESS 69 0.0019
906 RASH PAPULAR 42 0.0019
907 HALLUCINATION 140 0.0019
908 CEREBRAL HAEMORRHAGE 66 0.0018
909 SKIN DISORDER 61 0.0018
910 INJECTION SITE PRURITUS 122 0.0018
911 IRRITABILITY 109 0.0018
912 DYSTONIA 35 0.0018
913 HALLUCINATION, VISUAL 38 0.0018
914 ADVERSE DRUG REACTION 160 0.0018
915 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 60 0.0018
916 PANCREATITIS 93 0.0018
917 DRY SKIN 229 0.0017
918 PRODUCT AVAILABILITY ISSUE 39 0.0017
919 MEDICATION ERROR 94 0.0017
920 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 120 0.0017
921 EXPIRED PRODUCT ADMINISTERED 56 0.0017
922 NEEDLE ISSUE 49 0.0017
923 MENTAL DISORDER 73 0.0017
924 DISTURBANCE IN ATTENTION 90 0.0017
925 WHITE BLOOD CELL COUNT DECREASED 180 0.0017
926 MUCOSAL INFLAMMATION 43 0.0016
927 INCORRECT DOSE ADMINISTERED BY DEVICE 43 0.0016
928 LEUKOPENIA 82 0.0016
929 COMA 78 0.0016
930 OSTEONECROSIS 53 0.0016
931 COGNITIVE DISORDER 75 0.0016
932 HEPATITIS 41 0.0016
933 THERAPEUTIC RESPONSE SHORTENED 53 0.0016
934 INJECTION SITE BRUISING 127 0.0016
935 NIGHTMARE 55 0.0016
936 URTICARIA 265 0.0016
937 DISEASE RECURRENCE 75 0.0016
938 NERVOUS SYSTEM DISORDER 49 0.0016
939 BLOOD CREATINE PHOSPHOKINASE INCREASED 45 0.0016
940 PLASMA CELL MYELOMA 60 0.0015
941 RHEUMATOID ARTHRITIS 174 0.0015
942 GLYCOSYLATED HAEMOGLOBIN INCREASED 38 0.0015
943 OVERDOSE 324 0.0015
944 DRUG INEFFECTIVE 1970 0.0015
945 JAUNDICE 40 0.0015
946 ALOPECIA 287 0.0015
947 BLOOD CHOLESTEROL INCREASED 68 0.0015
948 DRUG EXPOSURE DURING PREGNANCY 49 0.0014
949 EYE IRRITATION 82 0.0014
950 NEUTROPHIL COUNT DECREASED 58 0.0014
951 EPILEPSY 43 0.0014
952 INJECTION SITE HAEMORRHAGE 111 0.0014
953 INJECTION SITE ERYTHEMA 172 0.0014
954 PAIN OF SKIN 37 0.0014
955 ECZEMA 71 0.0014
956 MOOD ALTERED 37 0.0014
957 SKIN EXFOLIATION 111 0.0013
958 CONVULSION 75 0.0013
959 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 38 0.0013
960 ABNORMAL BEHAVIOUR 51 0.0013
961 MALIGNANT NEOPLASM PROGRESSION 130 0.0013
962 INCORRECT DRUG ADMINISTRATION DURATION 35 0.0012
963 SKIN IRRITATION 57 0.0012
964 EXPOSURE DURING PREGNANCY 76 0.0012
965 INJECTION SITE PAIN 369 0.0012
966 VAGINAL HAEMORRHAGE 52 0.0012
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 84 0.0012
968 INCORRECT ROUTE OF DRUG ADMINISTRATION 42 0.0012
969 NEUTROPENIA 156 0.0011
970 EMOTIONAL DISORDER 35 0.0011
971 ACCIDENTAL EXPOSURE TO PRODUCT 114 0.0011
972 DRUG EFFECT DECREASED 57 0.0011
973 ANGIOEDEMA 46 0.0010
974 INJECTION SITE SWELLING 76 0.0010
975 DRUG EFFECT INCOMPLETE 36 0.0010
976 SUICIDAL IDEATION 86 0.0009
977 AGGRESSION 46 0.0009
978 MULTIPLE SCLEROSIS 40 0.0008
979 PRODUCT STORAGE ERROR 67 0.0008
980 TOXICITY TO VARIOUS AGENTS 129 0.0008
981 DRUG DOSE OMISSION BY DEVICE 54 0.0007
982 EMOTIONAL DISTRESS 83 0.0007
983 NO ADVERSE EVENT 121 0.0007
984 BREAST CANCER 57 0.0006
985 PROSTATE CANCER 49 0.0006
986 ACNE 45 0.0006
987 INJECTION SITE REACTION 40 0.0006
988 PSORIASIS 75 0.0006
989 INTENTIONAL OVERDOSE 35 0.0005
990 TREATMENT FAILURE 44 0.0005
991 SKIN BURNING SENSATION 38 0.0005
992 DRUG WITHDRAWAL SYNDROME 43 0.0005
993 DRUG ABUSE 39 0.0005
994 DRUG DEPENDENCE 68 0.0004